Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, January 12, 2023
[ Thu, Jan 12th 2023
] - WOPRAI
[ Thu, Jan 12th 2023
] - WOPRAI
[ Thu, Jan 12th 2023
] - WOPRAI
[ Thu, Jan 12th 2023
] - WOPRAI
[ Thu, Jan 12th 2023
] - WOPRAI
[ Thu, Jan 12th 2023
] - WOPRAI
[ Thu, Jan 12th 2023
] - WOPRAI
[ Thu, Jan 12th 2023
] - WOPRAI
[ Thu, Jan 12th 2023
] - WOPRAI
[ Thu, Jan 12th 2023
] - WOPRAI
Wed, January 11, 2023
[ Wed, Jan 11th 2023
] - WOPRAI
[ Wed, Jan 11th 2023
] - WOPRAI
[ Wed, Jan 11th 2023
] - WOPRAI
[ Wed, Jan 11th 2023
] - WOPRAI
[ Wed, Jan 11th 2023
] - WOPRAI
[ Wed, Jan 11th 2023
] - WOPRAI
[ Wed, Jan 11th 2023
] - WOPRAI
[ Wed, Jan 11th 2023
] - WOPRAI
[ Wed, Jan 11th 2023
] - WOPRAI
[ Wed, Jan 11th 2023
] - WOPRAI
[ Wed, Jan 11th 2023
] - WOPRAI
[ Wed, Jan 11th 2023
] - WOPRAI
[ Wed, Jan 11th 2023
] - WOPRAI
[ Wed, Jan 11th 2023
] - WOPRAI
[ Wed, Jan 11th 2023
] - WOPRAI
[ Wed, Jan 11th 2023
] - WOPRAI
[ Wed, Jan 11th 2023
] - WOPRAI
[ Wed, Jan 11th 2023
] - WOPRAI
[ Wed, Jan 11th 2023
] - WOPRAI
Do Kim Maintained (TVTX) at Buy with Increased Target to $42 on, Jan 11th, 2023
Do Kim of Piper Sandler, Maintained "Travere Therapeutics, Inc." (TVTX) at Buy with Increased Target from $38 to $42 on, Jan 11th, 2023.
Do has made no other calls on TVTX in the last 4 months.
There are 3 other peers that have a rating on TVTX. Out of the 3 peers that are also analyzing TVTX, 1 agrees with Do's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Alex Thompson of "Stifel" Initiated at Hold and Held Target at $22 on, Wednesday, December 14th, 2022
These are the ratings of the 2 analyists that currently disagree with Do
- Joseph Schwartz of "SVB Leerink" Maintained at Buy with Decreased Target to $38 on, Thursday, October 20th, 2022
- Ed Arce of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $36 on, Monday, October 17th, 2022
